Search

everythinglearnresearchcommunity

for

Search:↓

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Trichoscopy effectively diagnoses eyebrow loss, distinguishing between alopecia areata and frontal fibrosing alopecia.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Mogamulizumab can cause hair loss and skin rashes.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

A woman's hair loss led to discovering she had lupus.

Betamethasone is more effective for hair regrowth than latanoprost but has more side effects.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Trichoscopy helps effectively tell apart different types of patchy hair loss in Egyptian patients.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.

Eyelash regrowth occurred after eyelid surgery in a man with severe hair loss.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Reflectance confocal microscopy can help tell apart scarring from non-scarring hair loss.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

A 7-year-old boy's unusual hair loss was caused by a herpes infection and healed after treatment.